Japan Money Stock Data Due On Monday
RTTNews
|
43 days ago
(RTTNews) - Japan will on Monday release April figures for money stock, highlighting a light day for Asia-Pacific economic activity. The M2 money stock is expected to hold steady, higher by 2.5 percent.
New Zealand will see April results for the Performance of Services Index from BusinessNZ; in March, the index score was 47.5.
Australia will see April results for the indexes of business confidence and conditions from NAB; in March, their scores were +1 and +9, respectively.
Taiwan will provide Q1 figures for gross domestic product, with forecasts suggesting an increase of 6.51 percent on year - accelerating from 4.93 percent in the previous three months.
read more
Canadian Market Up Firmly, Looks Set To End On Strong Note
The Canadian market is up firmly in positive territory Monday afternoon with stocks from several sectors rallying sharply on sustained buying interest ahead of some crucial economic data and speeches from Fed officials.
RTTNews
|
4h 55min ago
U.S. Stocks Turning In Mixed Performance
U.S. stocks are turning in a mixed performance on Monday, as investors look ahead to some crucial economic data, and comments from Fed officials for clues about the central bank's monetary policy outlook.
RTTNews
|
5h 29min ago
Pound Strengthens Against Majors
The pound edged higher against its major counterparts in the New York session on Monday.
RTTNews
|
5h 35min ago
Swiss Market Ends On Strong Note
After opening on a slightly sluggish note, the Switzerland market gained in strength on Monday thanks to sustained buying at several counters amid optimism about interest rate cuts by major central banks.
RTTNews
|
5h 50min ago
European Stocks Close On Firm Note
European stocks closed on a firm note on Monday as bond yields dropped and investors digested some corporate news, while looking ahead to fresh economic data, the U.S. Presidential debate, and France's snap parliamentary polls.
RTTNews
|
6h 3min ago
SELLAS Says FDA Grants Rare Pediatric Disease Designation For SLS009 To Treat Pediatric ALL
Biopharmaceutical company SELLAS Life Sciences Group, Inc. (SLS) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to SLS009, a highly selective CDK9 inhibitor, for the treatment of pediatric acute lymphoblastic leukemia (ALL).
RTTNews
|
10h 0min ago
Dollar Rises As Fed Perceived More Hawkish Than Peers
The Dollar gained during the week ended June 21 amidst rising perception that the Fed was more hawkish than other major central banks.
RTTNews
|
10h 16min ago
VCI Global To Invest Up To $30 Mln In TalkingData Group
VCI Global Ltd. (VCIG) on Monday signed an agreement to invest up to $30 million in TalkingData Group Holding Ltd.
RTTNews
|
10h 21min ago